homocysteine and Abnormal Movements

homocysteine has been researched along with Abnormal Movements in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Kim, MS; Park, DG; Shin, IJ; Yoon, JH	1
Litvinenko, IV; Mogil'naya, VI; Odinak, MM; Perstnev, SV	1
Müller, T	1
Armenise, E; de Mari, M; Defazio, G; Dell'Aquila, C; Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, P; Lamberti, SV; Livrea, P; Zoccolella, S	1

Reviews

1 review(s) available for homocysteine and Abnormal Movements

Article	Year
Motor complications, levodopa metabolism and progression of Parkinson's disease. Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:7 Topics: Animals; Arteriosclerosis; Catechol O-Methyltransferase; Disease Progression; Dopamine; Dyskinesias; Enzyme Inhibitors; Free Radicals; Homocysteine; Humans; Levodopa; Nerve Degeneration; Parkinson Disease; Synaptic Transmission	2011

Trials

1 trial(s) available for homocysteine and Abnormal Movements

Article	Year
Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia. Neuroscience and behavioral physiology, 2010, Volume: 40, Issue:2 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Homocysteine; Humans; Levodopa; Memantine; Neuropsychological Tests; Nootropic Agents; Parkinson Disease; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome	2010

Article

Year

Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia.

Neuroscience and behavioral physiology, 2010, Volume: 40, Issue:2

Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Homocysteine; Humans; Levodopa; Memantine; Neuropsychological Tests; Nootropic Agents; Parkinson Disease; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome

2010

Other Studies

2 other study(ies) available for homocysteine and Abnormal Movements

Article	Year
Subthalamic deep brain stimulation improves vascular endothelial function in Parkinson's disease. Parkinsonism & related disorders, 2023, Volume: 116 Topics: Deep Brain Stimulation; Dyskinesias; Homocysteine; Humans; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome	2023
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias. Clinical chemistry and laboratory medicine, 2006, Volume: 44, Issue:7 Topics: Cross-Sectional Studies; Dyskinesias; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2006